Peptide Association
AboutPeptidesNewsBlogRegulatoryFind a Doctor

Peptide Database

86 therapeutic peptides with research summaries, clinical findings, and regulatory status.

AllMetabolicRecoveryHormoneReproductiveCognitiveLongevityImmunePerformanceBoneRenalCardiovascularHematologyOncologyGastrointestinalPainDermatologyAntimicrobialDiagnostic
FDA ApprovedIn Clinical TrialsInvestigationalResearch Phase
Showing 1 peptide in DiagnosticClear filters
DiagnosticFDA Approved

Pentagastrin

A synthetic pentapeptide containing the C-terminal tetrapeptide sequence of gastrin (Trp-Met-Asp-Phe-NH2) linked to beta-alanine. Pentagastrin stimulates gastric acid secretion by binding to cholecystokinin-2 (CCK2) receptors on parietal cells, and stimulates calcitonin release from thyroid C-cells. It has been used as a diagnostic agent for both gastric acid secretory capacity testing and provocative testing for medullary thyroid carcinoma (MTC).

Subcutaneous injection, Intramuscular injection
Peptide Association

Setting standards for physician-guided peptide therapy. Connecting patients with trusted, credentialed providers.

Free: 2026 Peptide Safety Checklist

7 provider questionsRed flag guide503A vs 503B comparison

Join 2,400+ readers. No spam, unsubscribe anytime.

FOR EDUCATIONAL AND RESEARCH PURPOSES ONLY.

This content is not medical advice. Nothing on this site is intended to replace consultation with a licensed healthcare provider.

About•Peptides•News•Blog•Regulatory•Find a Doctor•Contact
© 2026 Peptide Association LLC. All rights reserved.